Holocene Advisors’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $302M | Sell |
4,321,629
-124,752
| -3% | -$8.72M | 0.74% | 26 |
|
|
2025
Q1 | $327M | Buy |
4,446,381
+145,980
| +3% | +$10.7M | 0.95% | 26 |
|
|
2024
Q4 | $282M | Buy |
+4,300,401
| New | +$282M | 0.9% | 18 |
|
|
2024
Q3 | – | Sell |
-2,529,024
| Closed | -$197M | – | 715 |
|
|
2024
Q2 | $197M | Sell |
2,529,024
-2,944,348
| -54% | -$230M | 0.82% | 29 |
|
|
2024
Q1 | $371M | Buy |
5,473,372
+1,295,279
| +31% | +$87.8M | 1.36% | 5 |
|
|
2023
Q4 | $281M | Buy |
4,178,093
+1,702,482
| +69% | +$115M | 1.1% | 10 |
|
|
2023
Q3 | $168M | Buy |
2,475,611
+774,722
| +46% | +$52.5M | 0.73% | 36 |
|
|
2023
Q2 | $122M | Sell |
1,700,889
-10,607
| -0.6% | -$759K | 0.52% | 60 |
|
|
2023
Q1 | $119M | Sell |
1,711,496
-689,168
| -29% | -$47.8M | 0.58% | 52 |
|
|
2022
Q4 | $163M | Buy |
2,400,664
+301,632
| +14% | +$20.5M | 0.99% | 19 |
|
|
2022
Q3 | $115M | Buy |
2,099,032
+356,026
| +20% | +$19.5M | 0.74% | 45 |
|
|
2022
Q2 | $115M | Buy |
+1,743,006
| New | +$115M | 0.7% | 43 |
|
|
2021
Q4 | – | Sell |
-1,149,393
| Closed | -$69M | – | 848 |
|
|
2021
Q3 | $69M | Buy |
1,149,393
+279,399
| +32% | +$16.8M | 0.38% | 82 |
|
|
2021
Q2 | $52.1M | Sell |
869,994
-299,187
| -26% | -$17.9M | 0.29% | 105 |
|
|
2021
Q1 | $58.1M | Buy |
+1,169,181
| New | +$58.1M | 0.36% | 85 |
|
|
2020
Q3 | – | Sell |
-316,251
| Closed | -$16.7M | – | 654 |
|
|
2020
Q2 | $16.7M | Buy |
+316,251
| New | +$16.7M | 0.15% | 149 |
|
|
2020
Q1 | – | Sell |
-165,275
| Closed | -$8.24M | – | 665 |
|
|
2019
Q4 | $8.24M | Sell |
165,275
-1,084,967
| -87% | -$54.1M | 0.07% | 149 |
|
|
2019
Q3 | $55.7M | Buy |
1,250,242
+736,876
| +144% | +$32.8M | 0.57% | 55 |
|
|
2019
Q2 | $21.2M | Buy |
+513,366
| New | +$21.2M | 0.27% | 98 |
|